Avelox Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

BTZ-043 Dose Evaluation in Combination and Selection
Conditions:   Tuberculosis, Pulmonary;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Bedaquiline;   Drug: Delamanid;   Drug: Moxifloxacin Sponsors:   Michael Hoelscher;   Radboud University Medical Center;   University of California, San Francisco;   University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

A TQTc Study for Omaveloxolone
Condition:   Health Adult Subjects Interventions:   Drug: Omaveloxolone;   Drug: Moxifloxacin Sponsors:   Reata Pharmaceuticals, Inc.;   Celerion;   Q2 Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

BTZ-043 Dose Evaluation in Combination and Selection
Conditions:   Tuberculosis, Pulmonary;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Bedaquiline;   Drug: Delamanid;   Drug: Moxifloxacin Sponsors:   Michael Hoelscher;   Radboud University Medical Center;   University of California, San Francisco;   University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

A TQTc Study for Omaveloxolone
Condition:   Health Adult Subjects Interventions:   Drug: Omaveloxolone;   Drug: Moxifloxacin Sponsors:   Reata Pharmaceuticals, Inc.;   Celerion;   Q2 Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

BTZ-043 Dose Evaluation in Combination and Selection
Conditions:   Tuberculosis, Pulmonary;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Bedaquiline;   Drug: Delamanid;   Drug: Moxifloxacin Sponsors:   Michael Hoelscher;   Radboud University Medical Center;   University of California, San Francisco;   University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials

A TQTc Study for Omaveloxolone
Condition:   Health Adult Subjects Interventions:   Drug: Omaveloxolone;   Drug: Moxifloxacin Sponsors:   Reata Pharmaceuticals, Inc.;   Celerion;   Q2 Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2023 Category: Research Source Type: clinical trials

BTZ-043 Dose Evaluation in Combination and Selection
Conditions:   Tuberculosis, Pulmonary;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Bedaquiline;   Drug: Delamanid;   Drug: Moxifloxacin Sponsors:   Michael Hoelscher;   Radboud University Medical Center;   University of California, San Francisco;   University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2023 Category: Research Source Type: clinical trials

A TQTc Study for Omaveloxolone
Condition:   Health Adult Subjects Interventions:   Drug: Omaveloxolone;   Drug: Moxifloxacin Sponsors:   Reata Pharmaceuticals, Inc.;   Celerion;   Q2 Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2023 Category: Research Source Type: clinical trials

BTZ-043 Dose Evaluation in Combination and Selection
Conditions:   Tuberculosis, Pulmonary;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Bedaquiline;   Drug: Delamanid;   Drug: Moxifloxacin Sponsors:   Michael Hoelscher;   Radboud University Medical Center;   University of California, San Francisco;   University College, London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2023 Category: Research Source Type: clinical trials

A TQTc Study for Omaveloxolone
Condition:   Health Adult Subjects Interventions:   Drug: Omaveloxolone;   Drug: Moxifloxacin Sponsors:   Reata Pharmaceuticals, Inc.;   Celerion;   Q2 Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects
Condition:   Postpartum Hemorrhage Interventions:   Drug: Carbetocin;   Drug: Placebo;   Drug: Placebo and Moxifloxacin Sponsor:   Ferring Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials

Study to Evaluate the Effect of Aficamten Administration on QT/QTc Interval
Condition:   Healthy Participants Interventions:   Drug: Aficamten;   Drug: Aficamten-matching Placebo;   Drug: Moxifloxacin Sponsor:   Cytokinetics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate the Effect of Carbetocin on the QT/QTc Interval in Healthy Subjects
Condition:   Postpartum Hemorrhage Interventions:   Drug: Carbetocin;   Drug: Placebo;   Drug: Placebo and Moxifloxacin Sponsor:   Ferring Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials